NCT02293148 - Single Dose, Pharmacokinetic, Safety, Tolerability and QTc Study of GSK1278863 in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 17, 2014

Primary Completion Date

March 10, 2015

Study Completion Date

March 10, 2015

Conditions

Anaemia

Interventions

DRUG

GSK1278863 75 mg

A round, biconvex, white film coated tablet available in two doses (25 and 100 mg)

DRUG

GSK1278863 500 mg

A round, biconvex, white film coated tablet available in two doses (25 and 100 mg)

DRUG

Moxifloxacin 400 mg

Oblong, dull red, film-coated, convex tablets with M400 on one side

DRUG

Placebo matching GSK1278863

A round, biconvex, white film coated tablet as matching placebo for GSK1278863

DRUG

Placebo matching Moxifloxacin

Capsule shaped white film coated tablet as matching placebo for Moxifloxacin

Trial Locations (1)

GSK Investigational Site, Overland Park